Pfizer Halts Pursuit Of Zyvox Indication Based On Mortality Signal
Pfizer will not pursue an indication for catheter-related infections for Zyvox (linezolid) after data from a Phase III trial indicated an increased risk of death among patients with the infections treated with the oxazolidinone antibiotic
You may also be interested in...
The Pharmaceutical Research and Manufacturers of America offers its first Clinical Trial Exceptional Service Award to Donald Batts (Michigan State University), Sharon Nachman (Stony Brook University) and Maryam Imam, an 11 year-old volunteer patient on March 14. The two researchers helped make advances in clinical trials that led to the development of Pfizer's Zyvox (linezolid) for treatment of drug-resistant bacterial infections...
The virtual J.P. Morgan Healthcare meeting was missing the usual energy but still had substance.
US vaccination campaign will pick up speed now that access is broadening, leaders from Operation Warp Speed, Pfizer, Moderna, McKesson and CVS Health say at a J.P. Morgan panel discussion.